Community Outbreak of HIV Infection Linked to Injection Drug Use of Oxymorphone — Indiana, 2015

On January 23, 2015, the Indiana State Department of Health (ISDH) began an ongoing investigation of an outbreak of human immunodeficiency virus (HIV) infection, after Indiana disease intervention specialists reported 11 confirmed HIV cases traced to a rural county in southeastern Indiana. Historically, fewer than five cases of HIV infection have been reported annually in this county. The majority of cases were in residents of the same community and were linked to syringe-sharing partners injecting the prescription opioid oxymorphone (a powerful oral semi-synthetic opioid analgesic). As of April 21, ISDH had diagnosed HIV infection in 135 persons (129 with confirmed HIV infection and six with preliminarily positive results from rapid HIV testing that were pending confirmatory testing) in a community of 4,200 persons.

• Publication year

  2015

• Venue

  MMWR. Morbidity and mortality weekly report

• Publication date

  2015-05-01

• Fields of study

  Medicine

• Identifiers
  PMID 25928470PMCID 4584812
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• No references are available for this paper.

• Acceptability of and Implementation Supports for Video Directly Observed Treatment to Enhance Methadone Dosing Flexibility in a Multisite Opioid Treatment Program: Qualitative Rapid Needs Assessment Study

  2026cites this paper
• Single cell RNA transcriptome response to fentanyl use in persons with HIV infection

  2026cites this paper
• Medications to Treat Opioid Use Disorder.

  2026cites this paper
• HIV self-testing and partner notification strategies for key populations in low- to upper-middle-income countries: A mixed-methods systematic review

  2025cites this paper
• Estimating the Cost-Saving Threshold of a Rural Syringe Services Program Before and During the COVID-19 Pandemic

  2025cites this paper
• The Critical Importance of Clinical Use Case to Inform Point-of-Care Technology Development: A Case Study of Human Immunodeficiency Virus Nucleic Acid Assays in the United States.

  2025cites this paper
• Drug treatment and support service utilization amidst the COVID-19 pandemic among people who inject drugs in Baltimore, Maryland: An interrupted time-series analysis, 2015-2022.

  2025cites this paper
• HIV, STI, and Hepatitis Among People Who Inject Drugs at a Sexual Health Clinic in Melbourne, Australia: 2012 to 2022

  2025cites this paper
• The synthetic opioid fentanyl increases HIV replication in macrophages

  2025cites this paper
• Single cell RNA transcriptome response to fentanyl use in persons with hepatitis C virus infection

  2025cites this paper
• Serious Bacterial Infections and Hepatitis C Virus Among People Who Inject Drugs: A Syndemic or Intertwined Epidemics?

  2025cites this paper
• The “Unlinkables”: A Case Series of Overcoming Social Determinants of Health for Successful Linkage to Care for HIV from the ED

  2025cites this paper
• Hepatitis C Surveillance in the United States: Past, Present, and Future.

  2025cites this paper
• Infectious Complications of Substance Use: A Retrospective Cohort Study of Hospitalized Veterans

  2025cites this paper
• Initiating Injectable Buprenorphine in People Hospitalized With Infections

  2025cites this paper
• Trends in Black-White Disparities in HIV Diagnosis by Selected Characteristics, 2017‒2021—United States

  2024cites this paper
• Developing an ethical framework for the recruitment of people who inject drugs experiencing incarceration in HIV prevention research: a qualitative study

  2024cites this paper
• Addiction consult service involvement in PrEP and PEP delivery for patients who inject drugs admitted to an urban essential hospital

  2024cites this paper
• Overdose Experiences Among a Sample of Women in Jail with Opioid Use Disorder

  2024cites this paper
• In vitro test methods for evaluating high molecular weight polyethylene oxide polymer induced hemolytic and thrombotic potential.

  2024cites this paper
• Investigating and forecasting infectious disease dynamics using epidemiological and molecular surveillance data.

  2024cites this paper
• Oxymorphone and Oxycodone Pharmacy Purchases in US Counties: Prelude to the Largest Rural Human Immunodeficiency Virus Outbreak in US History

  2024cites this paper
• Drug preparation, injection-related infections, and harm reduction practices among a national sample of individuals entering treatment for opioid use disorder

  2024cites this paper
• Structural and social changes due to the COVID-19 pandemic and their impact on engagement in substance use disorder treatment services: a qualitative study among people with a recent history of injection drug use in Baltimore, Maryland

  2024cites this paper
• Opioid and other drug use and drug-related mortality as indicators of Hepatitis C and Human Immunodeficiency Virus in Oklahoma

  2024cites this paper
• Comparing the brief Holistic Health for HIV (3H+) to the Holistic Health Recovery Program (HHRP+) among people with HIV and opioid use disorder: Results from a randomized, controlled non-inferiority trial

  2024cites this paper
• Associations of HIV pre-exposure prophylaxis (PrEP) indication, HIV risk perception and unwillingness to use PrEP among people who inject drugs in Baltimore, MD

  2024cites this paper
• Homophily and social mixing in a small community: Implications for infectious disease transmission

  2024cites this paper
• How the rural risk environment underpins hepatitis C risk: Qualitative findings from rural southern Illinois, United States.

  2023cites this paper
• Testing and Case Rates of Gonorrhea, Chlamydia, Syphilis, and HIV among People with Substance Use Disorders in the Veterans Health Administration

  2023cites this paper
• Balancing Data Provision and Data Protection: A Natural Experiment With HIV and Syphilis Surveillance Data in the United States

  2023cites this paper
• Strategies to Eliminate Inequity in PrEP Services in the US South and Rural Communities

  2023cites this paper
• Revisiting the Oxycontin Reformulation: The Role of Licit Substitutes

  2023cites this paper
• A Dynamic Spatial Factor Model to Describe the Opioid Syndemic in Ohio

  2023cites this paper
• Correlates of Recent HIV Testing Among People Who Inject Drugs in Rural Areas: A Multi-site Cross-Sectional Study, 2018–2020

  2023cites this paper
• Social ecological factors and medication treatment for opioid use disorder among justice-involved rural and urban persons: the Geographic variation in Addiction Treatment Experiences (GATE) longitudinal cohort study protocol

  2023cites this paper
• Interest in treatment with injectable diacetylmorphine among people who use opioids in Baltimore City, Maryland (USA)

  2023cites this paper
• Harm Reduction: A Missing Piece to the Holistic Care of Patients Who Inject Drugs

  2023cites this paper
• Missed Opportunities for Prevention: Prevalence and Incidence of HIV and HCV Diagnoses Among a Cohort of Individuals Discharged from an Urban Hospital with Injection Drug Related Diagnoses, 2012-2019.

  2023cites this paper
• Prevention and Intervention with Young People as a Critical Public Health Strategy to Curtail the Opioid Epidemic: A Call to Action

  2023cites this paper
• A Census Tract-Level Examination of Diagnosed HIV Infection and Social Vulnerability Themes Among Black/African American, Hispanic/Latino, and White Adults, 2019—USA

  2023cites this paper
• Factors associated with receptive injection equipment sharing among people who inject drugs: findings from a multistate study at the start of the COVID-19 pandemic

  2023cites this paper
• HIV and HCV testing at clinical encounters among people who inject drugs, 2013–2018—Opportunities for increased testing and prevention

  2023cites this paper
• Determining Critical Overlap Concentration of Polyethylene Oxide to Support Excipient Safety Assessment of Opioid Products.

  2022cites this paper
• The effects of opioid policy changes on transitions from prescription opioids to heroin, fentanyl and injection drug use: a qualitative analysis

  2022cites this paper
• Long-Acting Injectable Human Immunodeficiency Virus Pre-Exposure Prophylaxis Preferred Over Other Modalities Among People Who Inject Drugs: Findings from a Qualitative Study in California

  2022cites this paper
• Management of Infective Endocarditis in People Who Inject Drugs: A Scientific Statement From the American Heart Association

  2022cites this paper
• Exploring the impact of the COVID-19 pandemic on syringe services programs in rural Kentucky

  2022cites this paper
• Health harms of non-medical prescription opioid use: A systematic review.

  2022cites this paper
• Prevalence of mental health conditions among people living with HIV during the COVID‐19 pandemic: A rapid systematic review and meta‐analysis

  2022cites this paper
• Testing a digitally distributed method to recruit a network of community organizations to fight the consequences of the drug epidemic: A study in 13 American states.

  2022cites this paper
• TRENDS IN HIV CARE OUTCOMES AMONG ADULTS AND ADOLESCENTS IN THE U.S. SOUTH, 2015-2019.

  2022cites this paper
• A descriptive analysis of drivers under the influence of opioids in Kentucky.

  2022cites this paper
• Epigenome-wide association analyses of active injection drug use.

  2022cites this paper
• Logistical Facilitators and Barriers to PrEP Implementation in Methadone Clinic Settings: Provider and Staff Perspectives

  2022cites this paper
• Gaps in hepatitis C virus prevention and care for HIV-hepatitis C virus co-infected people who inject drugs in Canada.

  2022cites this paper
• SOPHIE: viral outbreak investigation and transmission history reconstruction in a joint phylogenetic and network theory framework

  2022influential citation
• Pre-Exposure Prophylaxis Barriers, Facilitators and Unmet Need Among Rural People Who Inject Drugs: A Qualitative Examination of Syringe Service Program Client Perspectives

  2022cites this paper
• Substance use disorders and social determinants of health from electronic medical records obtained during Kentucky's "triple wave".

  2022cites this paper
• Factors Associated with HIV Testing Among People Who Inject Drugs: Findings from a Multistate Study at the Start of the COVID-19 Pandemic

  2022cites this paper
• Estimated number of people who inject drugs in the United States.

  2022cites this paper
• A Census Tract–Level Examination of Diagnosed HIV Infection and Social Vulnerability among Black/African American, Hispanic/Latino, and White Adults, 2018: United States

  2022cites this paper
• A qualitative study on pharmacy policies toward over-the-counter syringe sales in a rural epicenter of US drug-related epidemics

  2022cites this paper
• Missed opportunities for healthcare providers to discuss HIV preexposure prophylaxis with people who inject drugs.

  2022cites this paper
• Six Moments of Infection Prevention in Injection Drug Use: An Educational Toolkit for Clinicians.

  2022cites this paper
• Systematic review and meta-analysis to estimate the burden of fatal and non-fatal overdose among people who inject drugs

  2022cites this paper
• Epidemiology of HIV in the USA: epidemic burden, inequities, contexts, and responses.

  2021cites this paper
• Homelessness, HIV testing, and the reach of public health efforts for people who inject drugs, San Francisco, California.

  2021cites this paper
• Expansion of Preexposure Prophylaxis Capacity in Response to an HIV Outbreak Among People Who Inject Drugs—Cabell County, West Virginia, 2019

  2021cites this paper
• Prevalence and Medication Treatment of Opioid Use Disorder Among Primary Care Patients with Hepatitis C and HIV

  2021cites this paper
• Opioid use disorder and endocarditis

  2021cites this paper
• Attitudes toward pharmacy-based HCV/HIV testing among people who use drugs in rural Kentucky.

  2021cites this paper
• Hepatitis C virus infection and polysubstance use among young adult people who inject drugs in a rural county of New Mexico.

  2021cites this paper
• HCV communication within ego-centric networks of men and women who inject drugs.

  2021cites this paper
• Supporting Any Positive Change: Harm Reduction as an Integral Pillar of Opioid Use Disorder Treatment

  2021cites this paper
• Factors Associated With Partner Notification, Testing, and Positivity in HIV Partner Services Programs in the United States, 2013 to 2017

  2021cites this paper
• Injection Drug Use and Healthcare Utilization in Patients Newly Diagnosed With HIV

  2021influential citation
• Use of Injection Drugs and Any Form of Methamphetamine in the Portland, OR Metro Area as a Driver of an HIV Time–Space Cluster: Clackamas, Multnomah, and Washington Counties, 2018–2020

  2021cites this paper
• Coordinating Systems of Care for HIV and Opioid Use Disorder: A Systematic Review of Enablers and Barriers to Integrated Service Access, and Systems and Tools Required for Implementation

  2021cites this paper
• Trends in HIV Care Outcomes Among Adults and Adolescents—33 Jurisdictions, United States, 2014–2018

  2021cites this paper
• Consider the Source: Associations between Syringe Sources and Risky Injection Behaviors in California’s Central Valley

  2021cites this paper
• Machine learning takes a village: Assessing neighbourhood-level vulnerability for an overdose and infectious disease outbreak.

  2021cites this paper
• Eliminating hepatitis C in a rural Appalachian county: protocol for the Kentucky Viral Hepatitis Treatment Study (KeY Treat), a phase IV, single-arm, open-label trial of sofosbuvir/velpatasvir for the treatment of hepatitis C

  2021cites this paper
• Faith leaders' perceptions of needle exchange programs in the rural Illinois Delta Region: Religion as a social determinant of health.

  2021cites this paper
• Factors Associated with Sterile Syringe Acquisition among People Who Inject Drugs in West Virginia

  2021cites this paper
• Drugs of Abuse and Their Impact on Viral Pathogenesis

  2021cites this paper
• The Past, Present, and Future of PrEP implementation Among People Who Use Drugs

  2021cites this paper
• Sexually Transmitted and Blood-borne Infections Among Patients Presenting to a Low-barrier Substance Use Disorder Medication Clinic

  2021cites this paper
• HIV detection by an emergency department HIV screening program during a regional outbreak among people who inject drugs

  2021cites this paper
• HIV in US Communities of Color

  2021cites this paper
• The Effect Of Buprenorphine On HIV Viral Suppression.

  2021cites this paper
• Syringe Coverage Among People Who Inject Drugs in West Virginia, USA

  2021cites this paper
• Difference in HIV testing behavior by injection status, among users of illicit drugs

  2021cites this paper
• Characterizing opioid-involved overdose risk in local communities: An opioid overdose vulnerability assessment across Indiana, 2017

  2021cites this paper
• Capacity of Rural Counties to Address an HIV or Hepatitis C Outbreak

  2021cites this paper
• HIV Pre-exposure Prophylaxis and Buprenorphine at a Drug Detoxification Center During the Opioid Epidemic: Opportunities and Challenges

  2021cites this paper
• Opioid Misuse Among Sexual and Gender Minorities in Texas: The Most Vulnerable Populations

  2021cites this paper
• Insight into an acute hepatitis A outbreak in Indiana

  2021cites this paper
• COVID‐19 and beyond: Lessons learned from emergency department HIV screening for population‐based screening in healthcare settings

  2021cites this paper
• Development of an in vitro system and model-based translational framework to assess haemolysis risk following intravenous abuse of medications containing polyethylene oxide.

  2020cites this paper